ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

KZIA Kazia Therapeutics Ltd

0.3887
0.01875 (5.07%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Kazia Therapeutics Ltd KZIA 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.01875 5.07% 0.3887 06:25:32
개장가 저가 고가 종가 전일 종가
0.3646 0.357 0.389 0.37 0.36995
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
21/03/202421:52PRNUSKazia Therapeutics licenses paxalisib to Sovargen for..
13/03/202421:00PRNUSKazia announces presentation of new data at AACR Annual..
22/02/202406:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/02/202423:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/02/202421:30PRNUSKazia Therapeutics Reports Early Conclusion of Clinical..
15/02/202405:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/02/202408:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/02/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
06/02/202406:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19/01/202406:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/01/202421:30PRNUSKAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTS
13/01/202406:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/12/202307:26EDGAR2Form F-3 - Registration statement by foreign private issuers
06/12/202322:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202308:02PRNUSKazia Therapeutics Announces Closing of $2 Million..
05/12/202306:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/12/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/12/202322:00PRNUSKazia Therapeutics Announces $2 Million Registered Direct..
30/11/202306:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/11/202306:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202321:01PRNUSKAZIA ANNOUNCES NON-BINDING LETTER OF INTENT FOR THE..
21/11/202321:30PRNUSKAZIA PROVIDES OVERVIEW OF PAXALISIB RELATED PRESENTATIONS..
21/11/202306:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/11/202306:30PRNUSKAZIA ANNOUNCES RECEIPT OF NASDAQ MINIMUM BID NOTIFICATION
15/11/202323:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202322:30PRNUSKAZIA ANNOUNCES THE RELEASE OF PNOC022 CLINICAL STUDY..
10/11/202321:01PRNUSKAZIA ANNOUNCES PUBLICATION IN MOLECULAR CANCER THERAPEUTICS..
02/11/202305:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202320:01PRNUSKAZIA THERAPEUTICS PROVIDES PRELIMINARY UPDATE FROM ONGOING..
26/10/202320:56EDGAR2Form 20-F - Annual and transition report of foreign private..
23/10/202321:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/10/202320:01PRNUSKAZIA THERAPEUTICS ANNOUNCES CLINICAL DATA AT ESMO 2023 FROM..
14/10/202305:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/10/202320:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/10/202320:01PRNUSKazia announces voluntary delisting from ASX
11/10/202304:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/10/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/10/202320:01PRNUSKAZIA THERAPEUTICS ANNOUNCES PRESENTATIONS AT UPCOMING..
29/09/202320:01PRNUSKAZIA THERAPEUTICS ANNOUNCES ACCEPTANCE OF LATE-BREAKING..
29/09/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/09/202320:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/08/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/07/202305:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/07/202320:00PRNUSKAZIA'S PAXALISIB RECEIVES FAST TRACK DESIGNATION FROM FDA..
08/06/202320:00PRNUSKAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO..
25/05/202320:01PRNUSKAZIA CEO, DR. JOHN FRIEND TO PARTICIPATE IN WHITE HOUSE..

최근 히스토리

Delayed Upgrade Clock